Macerich Company (MAC)
Official siteREAL ESTATE • REIT - RETAIL • NYSE
Market Cap: $7.40B
Last updated: Nov 17, 2026 at 11:06 AM ET
Macerich Company (MAC) P/E Ratio & Valuation History
Macerich Company (MAC) trades at 14.9x its 2026 FFO estimate. It trades at 9.4x sales and 2.6x book value. Its P/S is above its 5-year median of 4.5x.
Current Multiples
Its P/FFO of 14.9x uses the 2026 FFO estimate of $1.67 per share. Its enterprise value is 46.6x its EBITDA. Its free cash flow yield is 2.2%.
| Multiple | Value |
|---|---|
| P/FFO (2026 estimate) | 14.9x |
| P/E (trailing) | 35.6x |
| Forward P/E | N/A |
| Price to sales | 9.4x |
| Price to book | 2.6x |
| EV/EBITDA | 46.6x |
| Price to FCF | 44.7x |
| EV/FCF | 73.8x |
| PEG | 4.8 |
| FCF yield | 2.2% |
Historical Medians
Against its 10-year medians, its P/S is 84.3% above 5.1x and its P/B is 73.3% above 1.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 9.4x | 4.5x | 5.1x |
| P/B | 2.6x | 1.4x | 1.5x |
Valuation History
Over the 5 of the 10 year ends shown that have a P/E, its P/E ranged from 36.9x in 2019 to 307.7x in 2025. 2025 was the highest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $18.46 | 307.7x | 6.3x | 1.9x |
| 2024 | $19.92 | N/A | 6.0x | 1.7x |
| 2023 | $15.43 | N/A | 4.4x | 1.4x |
| 2022 | $11.26 | N/A | 3.5x | 0.8x |
| 2021 | $17.28 | N/A | 4.0x | 1.3x |
| 2020 | $10.67 | N/A | 2.2x | 0.7x |
| 2019 | $26.92 | 36.9x | 4.8x | 1.4x |
| 2018 | $43.28 | 61.0x | 7.9x | 2.1x |
| 2017 | $65.68 | 86.4x | 11.3x | 2.5x |
| 2016 | $70.84 | 81.4x | 11.8x | 2.5x |
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MAC
Is MAC stock overvalued?
Macerich Company trades at 14.9x its 2026 FFO estimate. GNG's valuation label for MAC is Overvalued.
What is MAC's price to sales ratio?
Macerich Company has a price to sales ratio of 9.4x.
What is MAC's PEG ratio?
Macerich Company has a PEG ratio of 4.8.
MAC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors